Skip to content
Open access

Multicentric and multifocal lobular breast cancer: selection of radical surgical treatment

2026 · Russian Medical Inquiry · Vol 10, pp. 474-479 · 0 citations

TL;DR

With strict patient selection, breast- conserving surgery and subcutaneous mastectomy may be considered alternatives to radical mastectomy without compromising long-term outcomes and to identify criteria for the safe performance of breast-conserving procedures.

Abstract

Background: invasive lobular breast carcinoma is characterized by a high frequency of multicentric and multifocal growth, which complicates the choice of the extent of surgery. The feasibility of breast-conserving surgery in this category of patients, particularly in early-stage disease, remains a matter of debate. Most recommendations are based on data obtained for ductal carcinoma, which may not always be applicable because of the biological features of lobular carcinoma, including diffuse growth and low sensitivity of standard imaging modalities. Aim: to compare immediate and long-term outcomes of surgical treatment in patients with stage I–IIIA multicentric or multifocal invasive lobular breast carcinoma treated with different surgical approaches, and to identify criteria for the safe performance of breast-conserving procedures. Materials and Methods: a single-center retrospective cohort study was conducted at the Moscow Multidisciplinary Clinical Center "Botkin Hospital". The analysis included 99 patients with histologically verified stage I–IIIA invasive lobular breast carcinoma treated in 2023–2025. Multicentric or multifocal growth was diagnosed in 38 patients (38.3%). All patients were divided into three groups according to the extent of surgery: radical mastectomy — 22 patients (57.0%), subcutaneous mastectomy with immediate reconstruction — 5 patients (13.1%), and breast-conserving surgery — 11 patients (30.0%). Results: in the multifocal-growth group, breast-conserving surgery was performed in 43% of cases, whereas in the multicentric-growth group it was performed in 21%; however, the difference between the rates of radical mastectomy and breast-conserving surgery did not reach statistical significance (p=0.16). Most tumors (55.2%) belonged to the luminal A subtype. At a median follow-up of 18 months (interquartile range, 12–24 months), disease progression was recorded in only one patient from the subcutaneous mastectomy group and manifested as distant bone metastases. Conclusion: multicentric and multifocal growth of invasive lobular breast carcinoma is not an absolute contraindication to breast-conserving surgery. The choice of surgical extent should be based on individual clinicomorphological factors, including the size and location of tumor foci, the feasibility of achieving negative resection margins, patient age, and tumor biological subtype. With strict patient selection, breast- conserving surgery and subcutaneous mastectomy may be considered alternatives to radical mastectomy without compromising long-term outcomes. KEYWORDS: lobular breast carcinoma, multicentric growth, multifocal growth, mastectomy, breast-conserving surgery, subcutaneous mastectomy, recurrence, survival. FOR CITATION: Tatarova A.A., Titov K.S., Lebedinsky I.N., Sokolov N.Yu., Lebedev S.S., Karseladze D.A. Multicentric and multifocal lobular breast cancer: selection of radical surgical treatment. Russian Medical Inquiry. 2026;10(7):474–479 (in Russ.). DOI: 10.32364/2587-6821- 2026-10-7-4

Read PDF

Similar papers

Case report Open access Oct 2026

Histologic heterogeneity in synchronous bilateral breast cancer: a case report and literature review

Synchronous bilateral primary breast cancer (sBPBC) accounts for 2.9%–3.9% of newly diagnosed breast cancers, while cases with discordant histologic subtypes are exceptionally rare. We report on a 59-year-old woman with synchronous left-sided invasive ductal carcinoma (IDC) and right-sided invasive lobular carcinoma (I...

X. Yuan, Wen Liu, Xiu-Xia Liu et al. · 0 citations
Review Open access Sep 2026

Metaplastic breast cancer: a clinicopathological analysis of nine cases highlighting diagnostic challenges and aggressive behavior

aggressive clinical behavior characterized by a high rate of distant metastasis (liver and brain) and a short-term mortality of 55.6% is observed in this single-center series of nine patients, highlighting the diagnostic complexity, pathological heterogeneity, and urgent need for multicenter collaborative studies with...

Yuan Shao, Bing-Hua Kan, Yan-Ni Li et al. · 0 citations
Open access Oct 2026

Diagnostic dilemma in a case of invasive mixed ductal lobular carcinoma of breast, a rare morphological subtype

Invasive mixed ductal lobular carcinoma (mDLC) is a rare subtype (3-5%) of invasive breast carcinoma. It is composed of mixed population of both invasive breast carcinoma of no special type (IBC-NST) and invasive lobular carcinoma (ILC) components within an individual tumor. We are presenting a case report of a 56yrs f...

Dimple Kapoor, Charu Nayyar, Vikas Garg et al. · 0 citations
Open access 2026

Papillary breast cancer: therapeutic and prognostic real-world data on a rare histologic type

Introduction: Papillary carcinoma is classified as a special subtype of breast neoplasm with an estimated incidence of 0.5% to 1.7% of all invasive breast carcinomas. Due to its rarity, treatment for these tumors is generally based on extrapolation from data on non-special tumor types. Objective: This study aimed to d...

W. Lima, Iara Garcia Nakashima, Y. Reis et al. · 0 citations
Open access Sep 2026

Personalization of the extent of surgical treatment for papillary thyroid carcinoma based on preoperative immunocytochemical risk stratification

Papillary thyroid microcarcinoma (PTMC) is the most commonly diagnosed form of thyroid cancer and generally has a favorable prognosis. However, a subset of PTMCs exhibits an aggressive biological course characterized by extrathyroidal extension, regional lymph node metastasis, and recurrence. Current recommendations of...

Y. Skrypko · 0 citations
Open access Aug 2026

Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes

This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).

A. R. Nunes-Reis, R. Paulinelli, R. Rahal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.